Free Virtual Consultations. Corona Virus Related Cases Click Here.

Man Killed in Bicycle Crash at Yorktown Avenue and Vasile Circle

Bicyclist Hit by SUV in Fatal Huntington Beach Accident

Huntington Beach, CA (April 1, 2020) – A bicyclist was killed in a crash in Huntington Beach. The fatal accident occurred on the evening of April 1 at Yorktown Avenue and Vasile Circle.

A man riding a bicycle was hit by a Honda Pilot at the intersection. The man died at the accident scene. The driver of the Honda, a 46-year-old resident of Huntington Beach, remained at the crash site. They were not injured. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Huntington Beach


May 18, 2020

Cottonwood Dairy Worker Killed in Accident

Employee Crushed by Farm Equipment in Fatal San Jacinto Accident...

November 6, 2019

Teen Killed in Crash on 15 Freeway Near Lenwood Road

Car Hits Guardrail, Truck in Fatal Barstow Accident...

April 14, 2020

Crash on Interstate 80 Near Harrison Street Causes Minor Injuries

4 Vehicles Collide in San Francisco Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.